miR-10b-3p downregulates the expression of CMTM5 (Figure 3A), and lower CMTM5 expression is associated with poor prognosis in patients with hepatocellular carcinoma (HCC)35. This evidence concerns the gene CMTM5 and hepatocellular carcinoma.